ELIQUIS 2.5 mg/1

ELIQUIS 2.5 mg is an oral medication containing apixaban, used to reduce the risk of blood clots. This film-coated tablet is commonly prescribed for conditions requiring anticoagulation therapy.

ELIQUIS 2.5 mg is primarily used to prevent blood clots in individuals with certain medical conditions. It is often prescribed for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). Additionally, it may be used to reduce the risk of stroke in patients with atrial fibrillation. ELIQUIS is also used to prevent blood clots in patients undergoing knee or hip replacement surgery. What is ELIQUIS used for? It is typically used for anticoagulation therapy to manage and prevent blood clots in various conditions.

Common effects of ELIQUIS 2.5 mg may include bleeding, bruising, and minor gastrointestinal discomfort. Some users may experience dizziness or fatigue. Serious side effects, such as severe bleeding, are rare but require immediate medical attention. It is important to monitor for any unusual symptoms while taking this medication.

ELIQUIS 2.5 mg should be handled with care to avoid bleeding risks. Patients should inform their healthcare provider about any history of bleeding disorders or current medications that may interact with apixaban. Regular monitoring and follow-up are recommended to ensure the medication's effectiveness and safety. Always store ELIQUIS in a cool, dry place away from direct sunlight.

ELIQUIS 2.5 mg may interact with other medications, including blood thinners, antiplatelet drugs, and certain antibiotics. Alcohol consumption should be limited as it can increase the risk of bleeding. Patients should also be cautious with nonsteroidal anti-inflammatory drugs (NSAIDs) and other medications that affect blood clotting. Always consult a healthcare provider before starting or stopping any medication while taking ELIQUIS.